Qube Research & Technologies (QRT)’s CME Group CME Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$768K	Sell	2,600 -12,100	-82%	-$3.59M	﹤0.01%	2604
2025 Q4	$4.01M	Sell	14,700 -1,800	-11%	-$489K	﹤0.01%	1894
2025 Q3	$4.46M	Buy	16,500 +10,800	+189%	+$2.94M	﹤0.01%	1822
2025 Q2	$1.57M	Buy	+5,700	New	+$1.55M	﹤0.01%	2292
2025 Q1	–	Sell	-300	Closed	-$69.7K	–	3535
2024 Q4	$69.7K	Sell	300 -1,800	-86%	-$414K	﹤0.01%	3050
2024 Q3	$463K	Buy	+2,100	New	+$435K	﹤0.01%	2298
2024 Q2	–	Sell	-8,000	Closed	-$1.72M	–	3908
2024 Q1	$1.72M	Sell	8,000 -16,400	-67%	-$3.45M	﹤0.01%	1842
2023 Q4	$5.14M	Buy	24,400 +11,600	+91%	+$2.48M	0.01%	1024
2023 Q3	$2.56M	Buy	+12,800	New	+$2.54M	0.01%	1253
2023 Q1	–	Sell	-35,000	Closed	-$5.89M	–	2592
2022 Q4	$5.89M	Hold	35,000	–	–	0.03%	623
2022 Q3	$6.2M	Hold	35,000	–	–	0.04%	552
2022 Q2	$7.17M	Hold	35,000	–	–	0.05%	386
2022 Q1	$8.32M	Buy	+35,000	New	+$8.22M	0.07%	367

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CME Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its CME Group (CME) stake by 249% in Q1 2026, buying an estimated $38.7M and bringing the position to 182,778 shares worth $54M. The position accounts for 0.06% of the portfolio, ranked #398.

Qube Research & Technologies (QRT) first reported a position in CME in Q1 2018 and has held it in 32 quarters since. The position peaked at $323M in Q2 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Qube Research & Technologies (QRT) held 182,778 shares of CME Group worth $54M as of Q1 2026.
Qube Research & Technologies (QRT) bought 130,439 CME Group shares in Q1 2026, an estimated $38.7M.
CME Group made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #398 holding.
Qube Research & Technologies (QRT) first reported a position in CME Group in Q1 2018 and has held it in 32 quarters since.
Qube Research & Technologies (QRT)'s CME Group position peaked at $323M in Q2 2024.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.